ROBERT J. LEFKOWITZ MD - 28 Apr 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Robert J. Lefkowitz
Issuer symbol
LXRX
Transactions as of
28 Apr 2024
Net transactions value
$0
Form type
4
Filing time
29 Apr 2024, 16:18:45 UTC
Previous filing
22 May 2023
Next filing
13 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise $0 +8,032 +20% $0.000000 48,364 28 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise $0 -8,032 -100% $0.000000* 0 28 Apr 2024 Common Stock 8,032 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.